A Single Center, Randomized, Single-blind, Active Comparator Phase 1 Clinical Trial to Assess the Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults
Latest Information Update: 11 Oct 2021
At a glance
- Drugs Pneumococcal vaccine conjugate 15-valent-EuBiologics (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions
- Sponsors EuBiologics
- 06 Oct 2021 Status changed from active, no longer recruiting to completed.
- 08 Apr 2021 New trial record